Literature DB >> 11306275

Congenital disorders of glycosylation: genetic model systems lead the way.

M Aebi1, T Hennet.   

Abstract

N-linked glycosylation is the most frequent modification of secretory proteins in eukaryotic cells. The highly conserved glycosylation process is initiated in the endoplasmic reticulum (ER), where the Glc(3)Man(9)GlcNAc(2) oligosaccharide is assembled on the lipid carrier dolichylpyrophosphate and then transferred to selected asparagine residues of polypeptide chains. In recent years, several inherited human diseases, congenital disorders of glycosylation (CDG), have been associated with deficiencies in this pathway. The ER-associated glycosylation pathway has been studied in the budding yeast Saccharomyces cerevisiae, and this model system has been invaluable in elucidating the molecular basis of novel types of CDG.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306275     DOI: 10.1016/s0962-8924(01)01925-0

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  36 in total

Review 1.  Mass spectrometric analysis of glycans in elucidating the pathogenesis of CDG type IIx .

Authors:  P B Mills; K Mills; N Mian; B G Winchester; P T Clayton
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

2.  The search for glycan function: fucosylation of the TGF-beta1 receptor is required for receptor activation.

Authors:  Harry Schachter
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-25       Impact factor: 11.205

3.  Solid-phase extraction of N-linked glycopeptides.

Authors:  Yuan Tian; Yong Zhou; Sarah Elliott; Ruedi Aebersold; Hui Zhang
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

Review 4.  Neurological aspects of human glycosylation disorders.

Authors:  Hudson H Freeze; Erik A Eklund; Bobby G Ng; Marc C Patterson
Journal:  Annu Rev Neurosci       Date:  2015-04-02       Impact factor: 12.449

5.  MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If.

Authors:  B Schenk; T Imbach; C G Frank; C E Grubenmann; G V Raymond; H Hurvitz; I Korn-Lubetzki; S Revel-Vik; A Raas-Rotschild; A S Luder; J Jaeken; E G Berger; G Matthijs; T Hennet; M Aebi
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

6.  The diversity of dolichol-linked precursors to Asn-linked glycans likely results from secondary loss of sets of glycosyltransferases.

Authors:  John Samuelson; Sulagna Banerjee; Paula Magnelli; Jike Cui; Daniel J Kelleher; Reid Gilmore; Phillips W Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

7.  The compartmentalisation of phosphorylated free oligosaccharides in cells from a CDG Ig patient reveals a novel ER-to-cytosol translocation process.

Authors:  Delphine Peric; Christelle Durrant-Arico; Christophe Delenda; Thierry Dupré; Pascale De Lonlay; Hélène Ogier de Baulny; Cécile Pelatan; Brigitte Bader-Meunier; Olivier Danos; Isabelle Chantret; Stuart E H Moore
Journal:  PLoS One       Date:  2010-07-20       Impact factor: 3.240

8.  Asparagine-linked glycosylation modifies voltage-dependent gating properties of CaV3.1-T-type Ca2+ channel.

Authors:  Yangong Liu; Pu Wang; Fangfang Ma; Mingqi Zheng; Gang Liu; Shinichiro Kume; Tatsuki Kurokawa; Katsushige Ono
Journal:  J Physiol Sci       Date:  2019-01-01       Impact factor: 2.781

9.  Identification and functional analysis of a defect in the human ALG9 gene: definition of congenital disorder of glycosylation type IL.

Authors:  Christian G Frank; Claudia E Grubenmann; Wafaa Eyaid; Eric G Berger; Markus Aebi; Thierry Hennet
Journal:  Am J Hum Genet       Date:  2004-05-17       Impact factor: 11.025

10.  Komrower Lecture. Congenital disorders of glycosylation (CDG): it's all in it!

Authors:  J Jaeken
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.